All
Friday Frontline: Cancer Updates, Research and Education on March 27, 2020
March 27th 2020From patients having to reschedule treatment appointments due to the novel coronavirus (COVID-19) outbreak, to clinical trials being put on hold, here’s everything you need to know about how the COVID-19 pandemic is impacting patients with cancer.
How Patients with Cancer, and Survivors, Can Manage Stress Through COVID-19 Uncertainty
March 27th 2020Dr. Shelley Johns, a researcher with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Regenstrief Institute, offers advice on how survivors and patients with cancer can recognize and manage the stress they may be experiencing as a result of the COVID-19 pandemic.
Screening and Treatment Can Significantly Reduce Cancer Deaths Over the Next 10 Years, Expert Says
March 27th 2020Estimates indicate that cancer will become the number one leading cause of death in the United States over the next five to 10 years. But, as one expert argued in a policy roundtable, there are ways to significantly decrease that rate.
Experience with Treatment Quarantine Provides Perspective on COVID-19 Pandemic
March 24th 2020Many patients with cancer and their caregivers have already had to live through their own forms of social distancing during intense treatment journeys. These lessons can provide perspective on the current COVID-19 pandemic and social distancing.
CDC Provides Patient Updates on Coronavirus
March 24th 2020The number of coronavirus (COVID-19) cases in the United States continues to grow, which could be extremely stressful for patients with cancer and their loved ones – especially as certain cancer therapies may cause a person to be immunocompromised.
Copper IUD Use Associated with Decreased Cervical Cancer Risk Compared Hormonal Intrauterine System
March 23rd 2020Women who use copper intrauterine devices (IUD) as a form of birth control may be at lower risk for high-grade cervical cancer compared with those who use a levonorgestrel-releasing intrauterine system.